Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ansell

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Thrombosis and Thrombolysis|October 10, 2015
Universal, class-specific and drug-specific reversal agents for the new oral anticoagulantsJack E Ansell
American Journal of Clinical Pathology|August 1, 1992
Imprecision of prothrombin time monitoring of oral anticoagulation. A survey of hospital laboratoriesJ E Ansell
American Journal of Clinical Oncology|August 6, 2009
Prophylaxis and treatment of venous thromboembolism in cancer patients: a reviewJack E Ansell
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 14, 2016
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer OptionsJack E Ansell
Seminars in Vascular Medicine|June 17, 2004
Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-managementJack E Ansell
Hematology/Oncology Clinics of North America|September 18, 2016
Reversal Agents for the Direct Oral AnticoagulantsJack E Ansell
Current Opinion in Pulmonary Medicine|May 17, 2000
Anticoagulation management clinics for the outpatient control of oral anticoagulantsJ E Ansell
Bailliere'S Clinical Haematology|May 20, 1999
Oral anticoagulants for the treatment of venous thromboembolismJ E Ansell
Archives of Internal Medicine|March 8, 1993
Oral anticoagulant therapy--50 years laterJ E Ansell
Progress in Cardiovascular Diseases|October 19, 2006
Inferior vena cava filters in venous thromboembolismKarin Weichman, Jack E Ansell
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Thrombosis and Thrombolysis|October 10, 2015
Universal, class-specific and drug-specific reversal agents for the new oral anticoagulantsJack E Ansell
American Journal of Clinical Pathology|August 1, 1992
Imprecision of prothrombin time monitoring of oral anticoagulation. A survey of hospital laboratoriesJ E Ansell
American Journal of Clinical Oncology|August 6, 2009
Prophylaxis and treatment of venous thromboembolism in cancer patients: a reviewJack E Ansell
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 14, 2016
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer OptionsJack E Ansell
Seminars in Vascular Medicine|June 17, 2004
Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-managementJack E Ansell
Hematology/Oncology Clinics of North America|September 18, 2016
Reversal Agents for the Direct Oral AnticoagulantsJack E Ansell
Current Opinion in Pulmonary Medicine|May 17, 2000
Anticoagulation management clinics for the outpatient control of oral anticoagulantsJ E Ansell
Bailliere'S Clinical Haematology|May 20, 1999
Oral anticoagulants for the treatment of venous thromboembolismJ E Ansell
Archives of Internal Medicine|March 8, 1993
Oral anticoagulant therapy--50 years laterJ E Ansell
Progress in Cardiovascular Diseases|October 19, 2006
Inferior vena cava filters in venous thromboembolismKarin Weichman, Jack E Ansell
Pageof 11